M&A Deal Summary

Eden Health Acquires Contigo Compounding

On August 19, 2025, Eden Health acquired life science company Contigo Compounding

Acquisition Highlights
  • This is Eden Health’s 1st transaction in the Life Science sector.
  • This is Eden Health’s 1st transaction in the United States.
  • This is Eden Health’s 1st transaction in New Mexico.

M&A Deal Summary

Date 2025-08-19
Target Contigo Compounding
Sector Life Science
Buyer(s) Eden Health
Deal Type Add-on Acquisition

Target

Contigo Compounding

Albuquerque, New Mexico, United States
Contigo Compounding is a licensed 503A compounding pharmacy specializing in sterile and non-sterile custom medications. Contigo Compounding is based in Albuquerque, New Mexico.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Eden Health

New York, New York, United States

Category Company
Sector Consumer Services
DESCRIPTION

Eden Health is a virtual-first medical provider that unites primary care, mental health support, and care navigation under a Collaborative Care model to simplify patients' complexity. The company works directly with employer groups and health plans to provide best-in-class, 24/7 virtual and in-person care that builds trust, engagement, and satisfaction. Eden Health is based in New York, New York.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Mexico M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1